ISSN: 1526-2375
Journal Home
Journal Guideline
Pain Medicine Q1 Unclaimed
Pain Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Neurology (clinical) with an H index of 121. It has a price of 2500 €. It has an SJR impact factor of 0,88 and it has a best quartile of Q1. It has an SJR impact factor of 0,88.
Pain Medicine focuses its scope in these topics and keywords: pain, chronic, patients, randomized, care, low, back, trial, regional, analgesia, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
2500 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,88
SJR Impact factor121
H Index207
Total Docs (Last Year)1174
Total Docs (3 years)6027
Total Refs2874
Total Cites (3 years)907
Citable Docs (3 years)2.32
Cites/Doc (2 years)29.12
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
A Case-Matching Study of the Analgesic Properties of Electroconvulsive Therapy
View moreWhy an "Ethics" Forum inPain Medicine?
View moreEfficacy of Interlaminar vs Transforaminal Epidural Steroid Injection for the Treatment of Chronic Unilateral Radicular Pain: Prospective, Randomized Study
View moreApplication of Telemedicine in a Pain Clinic: The Changing Face of Medical Practice
View morePAIN MEDICINE: A Pain Journal for the New Millennium
View morePain Medicine's Role in the Restoration and Reformation of Medical Ethics
View moreAntibody Activation and Immune Reactions: Potential Linkage to Pain and Neuropathy
View morePharmacologic Management Part 2: Lesser-Studied Neuropathic Pain Diseases
View moreSomatosensory Amplification and Affective Inhibition Are Elevated in Myofascial Face Pain
View moreThe Tower of Babel
View moreGenetic Testing for Enzymes of Drug Metabolism: Does It Have Clinical Utility for Pain Medicine at the Present Time? A Structured Review
View moreSmall Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats
View moreReasons for Opioid Discontinuation and Unintended Consequences Following Opioid Discontinuation Within the TOPCARE Trial
View moreClinical Pain Research: Challenges Across Cancers, Cultures, and Disciplines
View moreAmerican Academy of Pain Medicine: Up and to the Right
View morePain Tolerance Threshold: A Pilot Study of an Objective Measurement of Spinal Cord Stimulator Trial Results
View moreOral Ketamine in Hepatocellular Carcinoma
View moreA Case for Establishing Hospital Divisions of Pain Practice
View moreIdentifying Patients at Risk for Loss to Follow-up After Pain Center Treatment
View moreLetter to the Editor
View moreA Physician-Driven Solution - The Association for Medical Ethics, The Physician Payment Sunshine Act, and Ethical Challenges in Pain Medicine
View moreEditorial: The Suppression of Evidence-Basis in Pain Medicine and the Physician-Driven Quest to Re-establish It
View morePain, Ethics, and Public Policy
View moreNaissance
View more
Comments